Patient and Caregiver Perceptions of Airway Clearance Methods Used for Cystic Fibrosis

Table 1

Demographic characteristics.

Characteristics	Numbers	Percent
Identity of respondent	59
Patient	45	76%
(i) 18 years or older	31	53%
(ii) 17 years or younger	14	24%
Parent/guardian	14	24%
Spouse	0	0%
Patient’s gender	56
Male	31	55%
Female	25	45%
Nonbinary	0	0%
Transgender female	0	0%
Transgender male	0	0%
Others	0	0%
Prefer not to say	0	0%
Patient’s race/ethnicity^†	52
White	51	98%
Others	2	4%
American Indian/Alaska native	1	2%
Black/African American	1	2%
Asian	0	0%
Hispanic/Latinx	0	0%
Native Hawaiian/Pacific Islander	0	0%
CFTR modulator	53
Ivacaftor	2	4%
Lumacaftor/ivacaftor	1	2%
Tezacaftor/ivacaftor	2	4%
Elexacaftor/tezacaftor/ivacaftor	38	72%
None of these	10	19%
	Median	IQR
Patient’s age, N = 56	20	[13.5 – 30.0]
^‡FEV1% predicted, N = 28	90	[76.0 – 110.5]

The number of completed responses for each question is given. Percentage is calculated based on the number of complete responses for each question. ^†Respondents could choose more than one entry; percentages may exceed 100%. ^‡Patient reported spirometry results. N = 4 responses were removed because raw FEV₁ values were reported rather than FEV₁% predicted.